Scientists at the University of Oxford and pharmaceutical company GSK have collaborated to develop a revolutionary cancer vaccine. The vaccine aims to prevent cancer up to 20 years before it develops. This collaborative effort targets cells at the pre-cancerous stage when cancer is typically undetectable. Professor Sarah Blagden, director of the partnership, explains that cancer …
Cancer vaccines have always come with a frustrating catch. Unlike flu shots that work for millions of people, most cancer vaccines need to be custom-made for each patient. Doctors must extract tumor samples, analyze them, and build a vaccine tailored to that specific person’s cancer. By the time all that happens, months have passed, and …
The syringe contained no poison to kill cancer cells, no radioactive particles to burn through tissue, no harsh chemicals to ravage a patient’s body. Instead, it held something far more revolutionary: a set of molecular instructions that would transform a 67-year-old scientist’s immune system into a personalized cancer-hunting army. Janusz Racz didn’t know it as …